Article

# Synthesis of an Ethylenediaminetetraacetic Acid-like Ligand Based on Sucrose Scaffold and Complexation and Proton Relaxivity Studies of Its Gadolinium(III) Complex in Solution

Ping Zhang<fnref n="1" />, Cécile Barbot<fnref n="2" /> ID, Ramakrishna Gandikota<fnref n="2" />, Cenxiao Li<fnref n="1" />, Laura Gouriou<fnref n="2" /> ID, Géraldine Gouhier<fnref n="2" />,∗ and Chang-Chun Ling<fnref n="1" />,∗

**Abstract:** Sucrose constitutes a non-toxic, biodegradable, low-cost and readily available natural product. To expand its utility, we developed total synthesis for a ligand based on a sucrose scaffold for potential use as a metal chelation agent. The designed target (compound 2) has a metal-chelating functionality at both the C-6 and C-6' positions, which can provide a first coordination sphere of eight valencies. The designed total synthesis was highly efficient. To demonstrate the utility of the ligand, we studied its complexation with Gd(III). Using potentiometric titration and high-resolution mass spectrometry, we confirmed the formation of a 1:1 complex with Gd(III), which has a respectable formation constant of ~10<sup>13.4</sup>. Further NMR relaxivity studies show that the Gd(III) complex has a relaxivity (r1) of 7.6958 mmol<sup>-1</sup> s<sup>-1</sup>.

**Keywords:** sucrose; aminopolycarboxylate; lanthanide complex; stability constant; proton relaxivity

<figure><img src="image_1.png" /></figure>

check for
updates

**Citation:** Zhang, P.; Barbot, C.; Gandikota, R.; Li, C.; Gouriou, L.; Gouhier, G.; Ling, C.-C. Synthesis of an Ethylenediaminetetraacetic Acid-like Ligand Based on Sucrose Scaffold and Complexation and Proton Relaxivity Studies of Its Gadolinium(III) Complex in Solution. *Molecules* **2024**, *29*, 4688. https://doi.org/10.3390/molecules29194688

Academic Editor: Alistair J. Lees

Received: 28 August 2024

Revised: 21 September 2024

Accepted: 26 September 2024

Published: 3 October 2024

<figure><img src="image_2.png" /></figure>

**Copyright:** © 2024 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

## 1. Introduction

Sucrose or table sugar (1, Figure 1) is an inexpensive agricultural product primarily produced by sugarcane and sugar beet [1]. With an annual production of more than 180 million metric tons, sucrose constitutes a genuinely green, biorenewable and sustainable natural product. Due to its abundance and extremely low cost, sucrose has found many utilities in different fields, in addition to being primarily consumed as a natural sweetener to foods and other agricultural products, medicines and cosmetics [2]. For example, sucrose has been converted into biodegradable polymers [3–5], such as polyesters and polyurethanes, and other value-added commercial products, such as emulsifiers [3,6–8], fat substituents [9] and artificial sweeteners [10,11]. With the help of fermentation and technologies developed in chemical industries, sucrose has also found other important utilities, such as bio feedstock for the production of biofuels and others [12,13]. Structurally, sucrose is a disaccharide that is formed between α-D-glucopyranose and β-D-fructofuranose by condensing their anomeric hydroxyls together to form an α(1→2')glycosidic linkage (1, Figure 1). This makes sucrose a non-reducing sugar, which represents an advantage in chemical functionalization as it exists as a single stereoisomer. There are three primary hydroxyl groups at C-6, C-1' and C-6' that can be selectively activated, with two of the three hydroxyl groups (OH-6 and OH-6') being even more accessible than the third one because of their reduced steric hindrance. As a result of these chemical features, sucrose has become a valuable scaffold for designing crown ethers, cryptands and other macrocycles [3]. In this work, we wish to report another possible application that uses sucrose as a scaffold to design metal-binding

<footnote n="1">¹ Department of Chemistry, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada; zhap@ucalgary.ca (P.Z.); cenxiao.li@ucalgary.ca (C.L.)</footnote>

<footnote n="2">² University Rouen Normandie, INSA Rouen Normandie, CNRS, Normandie University, COBRA UMR 6014, INC3M FR 3038, F-76000 Rouen, France; cecile.barbot@univ-rouen.fr (C.B.); ramakrishna-kishore-kumar.gandikota@univ-rouen.fr (R.G.); laura.gouriou2@univ-rouen.fr (L.G.)</footnote>

<footnote>* Correspondence: geraldine.gouhier@univ-rouen.fr (G.G.); ccling@ucalgary.ca (C.-C.L.); Fax: +33-235522959 (G.G.); +1-403-289-9488 (C.-C.L.)</footnote>
aminopolycarboxylates [14], such as compound **2** (Figure 1), for chelating transition metal ions. Compound **2** is strategically functionalized with two iminodiacetate residues, respectively, at the C-6 and C-6' positions with the help of copper(I)-catalyzed alkyne-azide 1,3-dipolar cycloaddition (CuAAC) [15,16]. The two iminodiacetate residues with the two newly formed 1,2,3-triazole rings can potentially work together by providing eight coordinating sites as the first coordination sphere for lanthanides, such as gadolinium(III), whose complexes have been widely used in magnetic resonance imaging [17,18]. The hard acid Gd³⁺ favors basic donor atoms, such as nitrogen and charged oxygen, which explains why many ligands containing nitrogen and oxygen are used as chelating and decontaminating agents, such as EDTA (ethylenediaminetetraacetic acid), NTA (nitrilotriacetic acid) and EGTA (ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid).

<figure><img src="image_3.png" /><figcaption>**Figure 1.** Structures of sucrose disaccharide (1) and newly designed synthetic ligand (2) using sucrose as a scaffold.</figcaption></figure>

**2. Results and Discussion**

**2.1. *Chemical Synthesis and Characterization***

The targeted ligand (2) was synthesized by following a highly efficient five-step route, outlined in Scheme 1, using the commercially available sucrose (1) as a starting material. The hydroxyl groups at C-6 and C-6' positions were regioselectively activated with dibromination, using carbon tetrabromide and triphenylphosphine as the reagents at 70 °C in anhydrous pyridine. This did not affect the other more sterically hindered primary hydroxyl group at C-1'. The formed C-6, C-6'-dibromide (3) was not isolated but directly subjected to per-O-acetylation at 55 °C to afford crude per-O-acetylated 6,6'-dibromide (4), which again was not isolated but subjected to substitution with sodium azide in N,N-dimethylformamide at 70 °C overnight. This afforded the corresponding 6,6'-diazide (5), which was isolated in its pure form and had a very good yield (67% over three steps). The recorded ¹H NMR spectrum of compound 5 showed two sets of mutually coupled protons at a fairly shielded region, each of them appearing as a doublet of doublets (Figure S1). They were assigned to be the two sets of geminal protons, respectively, attached to azido-functionalized C-6' of the fructofuranosyl unit [3.62 ppm (*J* = 13.1, 4.2 Hz)/3.48 ppm (*J* = 13.1, 4.2 Hz)] and azido-functionalized C-6 of the glucopyranosyl unit [3.36 ppm (*J* = 13.1, 7.5 Hz)/3.27 ppm (*J* = 13.4, 5.9 Hz)], according to the 2D ¹H-¹H GCOSY correlation spectrum (Figure S3). On the other hand, an AB quartet was observed to be integrated for two protons at a more deshielded region, corresponding to the set of geminal protons attached to C-1' of the fructofuranosyl unit [4.19 ppm (*J* = 12.3 Hz) and 4.13 ppm (*J* = 12.3 Hz)]. The fact that these two protons were observed to be more deshielded (>4 ppm) is consistent with the attachment of a more electron-withdrawing O-acetyl group. Furthermore, the recorded ¹³C NMR spectrum (DEPTQ, Figure S2) and 2D ¹H-¹³C GHSQC heteronuclear correlation spectrum (Figure S4) revealed one primary carbon signal at 62.5 ppm (C-1'), which was more deshielded than the other two primary carbons at 52.7 (C-6') and 51.0 (C-6) respectively, further confirming that C-1' has an O-acetyl group attached, while both C-6' and C-6 are attached to an azide functional group.
<figure><img src="image_4.png" /><figcaption>**Scheme 1.** Synthetic route to the designed target ligand (2) from sucrose (1).</figcaption></figure>

With the fully protected 6,6'-diazide (5) in hand, we proceeded with the coupling reaction with the previously reported dimethyl N-propargyl iminodiacetate (6) [18] using copper(I) iodide as a catalyst and N,N-diisopropylethylamine as a base; this successfully yielded the corresponding conjugate 7, which was isolated in its pure form and had a very good yield (83%). The structural identity of compound 7 was confirmed by the presence of two singlets at 7.67 and 7.57 ppm, respectively (Figure S5); these two aromatic protons correspond to H-4 protons of the two newly formed 1,2,3-triazole rings. The two sets of geminal protons, respectively, attached to C-6' and C-6 shifted to a more deshielded region (4.45/4.30 ppm for H-6a'/H-6b' and 4.45/4.37 ppm for H-6a/H-6b) as a result of their proximity to the 1,2,3-triazole rings that have a deshielding effect due to their aromatic π-electron clouds.

To obtain the final target (2), compound 7 was first subjected to per-O-deacetylation in anhydrous methanol using a catalytic amount of sodium methoxide as a base. Trans-esterification afforded the intermediate (8), which was not isolated but directly subjected to full saponification with aqueous sodium hydroxide to afford the desired compound (2), isolated in sodium salt form by size-exclusion chromatography on Sephadex LH-20 using methanol as the eluent (86% yield). The structure of compound 2 was confirmed by 1D ¹H and ¹³C spectra (Figures 2, S9 and S10), and the observed ¹H and ¹³C signals were assigned with the support of 2D ¹H-¹H homonuclear GCOSY (see Figure S11) and ¹H-¹³C heteronuclear GHSQC (Figures 3 and S12) correlation spectra. As can be seen in the H-1 spectrum recorded in D₂O, the anomeric proton of the D-glucopyranosyl unit is observed at 5.44 ppm as a doublet with a small coupling constant (J = 3.7 Hz), corresponding to its α-anomeric configuration; this proton correlates to a carbon at 92.3 ppm (C-1), according to the GHSQC heteronuclear correlation spectrum. On the other hand, for the fructofuranosyl unit, the anomeric center C-2' can be observed at 104.2 ppm; there is no anomeric proton attached to C-2', as evidenced by the absence of correlation with C-2' from any protons in the GHSQC spectrum. The two geminal protons at C-1' of the fructofuranose are observed at 3.64 and 3.57 ppm as two mutually coupled doublets with a large coupling constant (J = 12.6 Hz). There are two sets of 1,2,3-triazole units, as evidenced by the two singlets at 8.37 and 8.32 ppm, corresponding to the H-4 aromatic
protons. The two pairs of iminoacetates attached to C-6 (Glu) and C-6' (Fru) are observed as two separate singlets at 3.90 and 3.88 ppm (two methylene protons) in the 1D proton NMR spectrum, suggesting that they have different chemical environments due to free rotation around the parent C-N single bond from the 1,2,3-triazolmethyl residue. On the other hand, we noticed that all methylene protons of the two iminoacetates shifted to a significantly more deshielded region compared to those of compound 7 (3.48 and 3.44 ppm), suggesting that both the tertiary amine centers of the iminoacetates in isolated compound 2 are likely to be protonated. The structure of compound 2 was further confirmed by electrospray high-resolution mass spectrometry (HRMS, negative), which showed a peak at *m/z* 733.2289 and another peak at *m/z* 366.1114, corresponding to the expected mono- and double-charged molecule ions that, respectively, have a molecular formula of C₂₆H₃₇N₈O₁₇ [M-H]⁻ (calculated *m/z*: 733.2282) and C₂₆H₃₆N₈O₁₇ [M-2H]²⁻ (calculated *m/z*: 366.1105).

<figure><img src="image_5.png" /><figcaption>**Figure 2.** Recorded NMR spectra and signal assignments of compound 2 in D₂O. Top: 1D ¹H spectrum (400 MHz); bottom: 1D ¹³C spectrum with the expansion of the ~48.0–79.5 ppm region.</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>**Figure 3.** Recorded 2D ¹H-¹³C heteronuclear correlation NMR spectrum (400 MHz) of compound 2 in D₂O.</figcaption></figure>

## 2.2. Protonation Studies of Compound 2 by Potentiometric Titration

As alluded to above, the structure of ligand 2 contains four carboxylate residues and two tertiary amine centers. Depending on the pH of the media, it can exist in different protonation states. Based on the well-known pKa values for acetic acid (~4.76) and triethylammonium (~10.75) and a literature report on the pKa of the protonated 1,2,3-triazolium compound, N-methyl-1,2,3-triazolium (~1.25) [19], we can safely ignore the protonation of the two 1,2,3-triazole rings in compound 2 since it only becomes relevant at very acidic
pHs. Thus, in less acidic solutions, ligand **2** contains essentially six prominent protonation sites that include the two tertiary amine centers and four carboxylates.

To facilitate the discussion of our potentiometric titration results, the following notations were adopted (Scheme 2): L represents the form of a compound with full deprotonation of all the above sites, LH2 represents the species with essentially full deprotonation of all four carboxylate groups, while the two tertiary amine centers remain protonated, and LH6 represents the form of compound **2** with protonation of all the four acetates and two tertiary amine centers. Other notations will be used accordingly to designate intermediate deprotonation states.

<figure><img src="image_7.png" /><figcaption>**Scheme 2.** The major protonation states of target ligand **2** and their designated notations.</figcaption></figure>

As the pH of the initial solution of isolated compound **2** in water was more than 7, we concluded that at this elevated pH, the four carboxylates are most likely deprotonated; this supports that the isolated compound structure is in the LH2 form, as suggested by the ¹H NMR experiment. We gradually added a solution of HCl in trimethylammonium chloride (0.1 M) to the initial solution to obtain a series of solutions with different HCl/compound **2** ratios (0→69.1) while maintaining the total volume constant (4.0 mL). To each prepared solution, potentiometric titrations were initiated using a titrant solution of tetramethylammonium hydroxide (0.05 M); the pHs of the solutions were recorded. This allowed us to obtain a series of titration curves (Figure 4). As can be seen, with increasing HCl/2 ratios, the form of the obtained curves becomes increasingly similar to that of pure HCl, while with decreasing HCl/2 ratios, the form of the curves becomes more representative of ligand **2** alone.

<figure><img src="image_8.png" /><figcaption>**Figure 4.** Potentiometric titrations of compound **2** (left). L: 0.5–3 µmol; extra HCl: 0–34.5 µmol in 0.1 M NMe₄Cl; total initial volume: 4.0 mL. Burette: [NMe₄OH] = 0.05 M, and calculated distribution curves (right) of different protonated species of compound **2** at different pHs: [compound **2**] = 5.0 × 10⁻⁴ M.</figcaption></figure>

The protonation constant $β_h$ for the following equilibrium is defined by Equation (1), where L represents the fully deprotonated form, and H is the proton (charges are omitted).

$$L + hH \rightleftharpoons LH_h; \quad \beta_h = \frac{[LH_h]}{[H]^h[L]} \quad (1)$$
As dissociation constants, *Ka* values are commonly defined by:

$$K_a = \frac{[H^][LH_{h-1}]}{[LH_h]} \qquad (2)$$

It is evident that:

$$pK_a = \log\beta_h - \log\beta_{h-1} \qquad (3)$$

Table 1 summarizes all the protonation constant values of compound 2 determined by titration curve refinement, together with the corresponding acidity constants. All the *pKa* values were ascribed to deprotonation of the carboxylate functions, followed by ammonium functions when increasing the base addition.

<table><caption>**Table 1.** Logarithmic values of the protonation constants of compound 2 determined by potentiometric titrations.</caption><thead><tr><th>Species</th><th>logβLH<sub>h</sub></th><th>pKa</th></tr></thead><tbody><tr><td>LH</td><td>8.28</td><td>8.28</td></tr><tr><td>LH<sub>2</sub></td><td>15.74</td><td>7.46</td></tr><tr><td>LH<sub>3</sub></td><td>18.34</td><td>2.60</td></tr></tbody></table>

I = 0.1 M (NMe₄Cl); T = 298 K; pKw = 13.78.

The last carboxylate group to be deprotonated, named LH3, had a *pKa* (LH3/LH2) equal to 2.6. The *pKa* values greater than 7 could be attributed to the formation of ammonium moieties, which is in agreement with the known values for these groups (LH2/LH: 7.46; LH/L: 8.28).

The obtained *pKa* values are in accordance with the literature for iminodiacetic acid (Ida) in an aqueous medium (Scheme 3) at the same ionic strength (0.1 M): *pKa*₁ = 2.68 in the case of the equilibrium Ida-H₂/Ida-H [20]. For the Ida-H₃/Ida-H₂ equilibrium, the reported *pKa* was 1.84, which is very low, and we were not able to reach it in our experiments.

<figure><img src="image_9.png" /><figcaption>**Scheme 3.** The three protonation states of iminodiacetic acids.</figcaption></figure>

However, the reported *pKa*₂ accounting for ida-H/ida was 9.47, which is less acidic than the LH/L value of 8.28. This can be explained by the difference in amino functionality, which, in our case, is linked to a triazole moiety through an intermediate methylene group. As the triazole ring is a strong electron-attracting group, this can slightly lower the *pKa* of LH species compared to that of iminodiacetic acid.

From the species diagram of compound 2 (Figure 4, right), at physiological pH, the majority of species would be LH2 in equilibrium with LH. Therefore, we conclude that all the carboxylate groups were deprotonated. This is consistent with our hypothesis based on the NMR experiment.

## 2.3. Complexation Studies of Gadolinium(III) with Compound 2 by High-Resolution Mass Spectrometry

To determine the formation of the complex between compound 2 and lanthanide metals, we selected gadolinium(III) as a model. A solution of compound 2 was mixed with a gadolinium(III) trichloride solution (1.1 equivalents). The pH of the solution was
then adjusted to 6~7, and the product formed was dialyzed against deionized water several times using a membrane with a molecular weight cut-off of ~500 daltons; this permits the removal of impurities with a molecular weight < 500 daltons. The solution was lyophilized to afford the ligand **2/Gd(III)** complex as a white solid. Unfortunately, due to the polyhydroxylated nature of the ligand, we were unable to find conditions to grow single crystals for structural determination by X-ray diffractometry. Additionally, due to the paramagnetic nature of Gd³⁺ ions, we were also unable to characterize the formed complex by NMR spectroscopy. However, the obtained solid was successfully analyzed by high-resolution mass spectrometry (electrospray, negative, Figure 5, top). The mass spectrum revealed a cluster of peaks centered at *m/z* 888.1281 (100%), together with other peaks. These peaks and the associated isotope patterns matched very well with the simulated spectrum (Figure 5, bottom) of the expected 1:1 complex [GdL]⁻ between compound **2** and Gd(III) ions and has a molecular formula of C₂₆H₃₄N₈O₁₇Gd [M-H]⁻ (calculated *m/z*: 888.1295 (100%)). This evidence confirms the successful formation of the 1:1 complex [GdL]⁻.

<figure><img src="image_10.png" /><figcaption>**Figure 5.** Electrospray ionization (negative) high-resolution spectrum (**top**) of formed 1:1 complex [GdL]⁻ with a molecular formula of C₂₆H₃₄N₈O₁₇Gd [M-H]⁻ between ligand **2** and Gd(III), and comparison to the isotope patterns of simulated mass spectrum (**bottom**).</figcaption></figure>

## 2.4. *Studies of Ligand 2/Gd(III) Complex by Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy*

In order to gain insight into the involvement of carboxylates in coordination with the Gd(III) metallic center, Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy was used to study ligand **2** and its complex with Gd(III). It is well-known that deprotonation of carboxylic acid results in the absence of strong bands around 1700 cm⁻¹ [21,22]. The resulting carboxylate (COO⁻) usually has two vibrational modes around 1600 and 1400 cm⁻¹ due to symmetric and antisymmetric stretching. As can be seen from Figure 6 (left), the ATR-FTIR spectrum of ligand **2** showed two stretching bands at 1618.3 and 1385.6 cm⁻¹, indicating the isolated ligand was, indeed, fully deprotonated from the carboxylates. Upon complexing with Gd(III), the peak corresponding to the asymmetric mode (1618.3 cm⁻¹) shifted to lower wavenumbers (1586.1 cm⁻¹), indicating that coordination through the carboxylate groups takes place (Figure 6).
<figure><img src="image_11.png" /><figcaption>**Figure 6.** ATR-FTIR spectra of ligand **2** (left) and ligand **2**/Gd(III) complex (right).</figcaption></figure>

## 2.5. Complexation Studies of Gadolinium(III) with Ligand **2** by Potentiometric Titration

To gain a deeper understanding of the complex formed between ligand **2** and gadolinium(III) in an aqueous solution, we next determined the stability constant using potentiometric titration. A series of solutions containing 0 to 1.11 equivalents of Gd(III)/ligand **2** were prepared by maintaining the initial concentrations of ligand **2** (5 × 10⁻⁴ M) and HCl (3.45 × 10⁻³ M) constant. Similarly, to each prepared solution, potentiometric titrations were performed by adding a titrant solution of tetramethylammonium hydroxide (0.05 M). The pH of the solution was recorded.

With M being the metal ion, L being the ligand, and H being the proton, the stability constants of the complexes with the general formula $M_m L_l H_h$ are expressed by the following equations (the charges are omitted):

$$ mM + lL + hH \rightleftharpoons M_m L_l H_h; \quad \beta_h = \frac{[M_m L_l H_h]}{[M]^m [L]^l [H]^h} \quad (4) $$

Thus, the dissociation constant $K_{mlh}$ can be defined similarly to the case of the free ligand, as follows:

$$ K_{mlh} = \frac{[H][M_m L_l H_{h-1}]}{[M_m L_l H_h]} \quad (5) $$

Analogously,

$$ pK_{mlh} = \log \beta_{mlh} - \log \beta_{mlh-1} \quad (6) $$

Figure **7** shows the obtained titration curves of the complex formed between ligand **2** and Gd(III). As can be seen, the GdL complex was formed over pH 3 as soon as the carboxylate moieties were deprotonated. For each solution, the pH slowly increased with the addition of the base; however, the pH of the solution with the greatest Gd:L ratio increased the slowest when the same amounts of the base were added. This can be explained by the fact that during the complexation of gadolinium(III), protons were released from the protonated sites of ligand **2**, acidifying the medium. As shown in Figure **4**, at pH 5, the speciation of the ligand alone has LH2 as the predominant species that corresponds to the form containing two protonated tertiary amines and four fully deprotonated carboxylate groups. At the same pH, in the presence of Gd(III), the titration necessitated about 2 moles of the base/mol of GdCl₃ to be added, and the speciation diagram indicates that the stoichiometry of the Gd:ligand **2** complex to be 1:1 as the predominant species (GdL, Figure **7**), supporting the removal of the two protons from the tertiary amines during complexation. Under physiological conditions (pH 7.4), there is an equilibrium between LH2 and LH of about equal proportions (Figure **4**). This pH corresponds to the second pKa of ligand **2** (Table **1**). As shown in Figure **7**, upon complexation at pH 7.4, the predominant species of Gd:ligand **2** remains 1:1 (i.e., GdL). In this case, complexation requires about 1.5 moles of the base/mol of gadolinium(III), corresponding to ~50% deprotonation of LH2. Finally, when the pH was well over the third pKa = 8.28, the fully deprotonated form (L) became the predominant species in equilibrium with LH (Figure **4**), thus the volumes of the
base added were similar for the gadolinium complex and ligand alone, as there were no more protons to be removed upon complexation.

<figure><img src="image_12.png" /><figcaption>**Figure 7.** Potentiometric titrations of ligand **2** in the presence of gadolinium(III) (**left**). Seventeen titrations were performed. Ligand **2**: 2.0 µmol; extra HCl: 13.82 µmol in NMe₄Cl (0.1 M); total initial volume: 4.0 mL. Burette: [NMe₄OH] = 0.05 M. The calculated distribution curve of 1:1 complex during titration [Gd]t = [Ligand **2**] = 5.0 × 10⁻⁴ M (**right**).</figcaption></figure>

Consequently, considering the whole results obtained for the ligand **2**/Gd(III) complex, the best chemical model that fits with the potentiometric curves for complexation corresponds to the formation of the essentially mononuclear GdL species with a ratio of 1:1 (Scheme 4); this represents more than 50% of the total species above pH 4, as illustrated in the calculated distribution curves (Figure 7, right). At pH 7.4, under physiological conditions, 98% of the ligand is on the GdL form, and 2% is on the GdLH-1 form. We can assess that, under these conditions, the complexation of Gd(III) was effective. When the Gd(III) concentration was higher than that of ligand **2**, precipitation occurred; this can be explained by the formation of hydroxylated species, such as Gd(OH)₃.

<figure><img src="image_13.png" /><figcaption>**Scheme 4.** Suggested complexation reaction of ligand **2** with Gd(III) ion results in the release of protons.</figcaption></figure>

The stability constants of the ligand **2**/Gd(III) complexes are reported in Table 2. The formation constant for the monometallic complex logβ<sub>GdLH</sub> was determined to be 13.4. This value is weaker than those reported for other aminocarboxylate ligands, such as EDTA (log βGd = 17.7) [23], and FDA-approved contrast agents (CAs), such as DTPA Magnevist™ (log βGd = 22.1), DOTA Dotarem™ (log βGd = 25.6) and DTPA.bma Omniscan™ (log βGd = 16.9) [24]. It is also lower than that of the cyclodextrin ligand, which we reported previously (log βGd = 25.09) [18]. However, the stability constant of the ligand **2**/Gd complex is much higher than those described for the native cyclodextrins/Gd(III) (log βGd = 2.5) [25] or tris(hydroxymethyl)aminomethane (Tris)/Gd(III) (log βGd = 2.67) complexes [26]. In comparison with Tris, the presence of N-acetate residues in ligand **2** clearly
shows advantages as a result of the introduction of two units of iminodiacetate groups; using sucrose as a scaffold to support the two fragments of iminodiacetates further allows an effective collaboration during the complexation of Gd(III). However, the larger macrocycle in the formed complex of ligand **2** also introduces enhanced conformation flexibility, thus accounting for the reduced stability compared to other ligands. On the other hand, the glycosidic linkage of ligand **2** represents an advantage because it is acid-labile and enzyme-active; thus, ligand **2** can be readily degraded and used as an environmentally friendly chelating reagent.

<table><caption>**Table 2.** Logarithmic values of the protonation constants of complex formed between ligand **2** and Gd(III) determined by potentiometric titrations.</caption><thead><tr><th>Species (M<sub>m</sub>L<sub>l</sub>H<sub>h</sub>)</th><th>mlh</th><th>logβ<sub>Species</sub></th><th>pK<sub>a</sub></th></tr></thead><tbody><tr><td>GdLH<sub>-1</sub></td><td>11-1</td><td>4.34</td><td>-</td></tr><tr><td>GdL</td><td>110</td><td>13.42</td><td>9.08</td></tr><tr><td>GdLH</td><td>111</td><td>16.44</td><td>3.02</td></tr></tbody></table>

I = 0.1 M (NMe₄Cl); T = 298 K.

The pM value measures the concentration of uncomplexed free metal ions left in the solution by a ligand. The variation in pM with pH for a particular metal-ligand complex can give useful information about the stability of the complex under different pHs; thus, the pM value provides a more complete picture of the effectiveness of a ligand when chelating a metal ion. The pGd (where pGd = -log[Gd<sub>free</sub>]) was calculated as a function of pH for a standard set of conditions (initial concentration: [Gd] = 10<sup>-6</sup> M, [L] = 10<sup>-5</sup> M) and is represented in Figure 8.

<figure><img src="image_14.png" /><figcaption>**Figure 8.** pGd value of Gd(III)-ligand **2** complexes as a function of pH. pGd = -log[Gd]<sub>free</sub>, [Gd]<sub>total</sub> = 1.0 µM, and [ligand]<sub>total</sub> = 10 µM.</figcaption></figure>

The pGd needs to be as high as possible to ensure negligible dissociation, as Gd(III) is toxic. The higher the pGd of a complex, the better affinity the ligand has toward the metal center. In the case of the current complex studied, the maximum pGd value (>14.5, Figure 8) is obtained at pH 9. Under physiological conditions (pH 7.4), pGd was determined to be ~13.1. When compared to the pGd values reported in the literature for other Gd(III) complexes, such as Gd-DOTA (pGd~18.1) [27], a tightly caged complex, and our previously reported 1:1 cyclodextrin ligand/Gd(III) complex (pGd~15.60) [18], the pGd value for the ligand **2**/Gd(III) complex is lower but still quite impressive, considering its larger and more flexible macrocycle and noncaged architecture.
## 2.6. Relaxivity Measurement of Ligand 2/Gd(III) Complex

Lanthanides are well-known to be capable of nine coordinations. The current ligand (2) can provide eight coordinating sites from two iminoacetates plus two 1,2,3-triazole units; this leaves the gadolinium(III) center to offer one additional site for dynamic water coordination to form the aquacomplex $[GdL(H_2O)]^−$ (Scheme 5) [18]. However, over pH ~7.5, hydroxocomplexes appeared for different ratios of Gd:ligand. In this case, the hydroxide ligand likely replaces the aqua ligand in the coordination sphere to form $[GdL(OH)]^{−2}$, as observed in the titration curves, with an inflection point occurring between pH 7 and 8.

<figure><img src="image_15.png" /><figcaption>**Scheme 5.** Suggested dynamic formation of aquacomplex of ligand 2/Gd(III) complex with water (pH < ~7.5).</figcaption></figure>

Relaxivity ($T_1$) measurements were performed on the ligand 2/Gd(III) complex at 37 °C on a 0.47 T (20 MHz) instrument using the “Inversion Recovery Pulse Sequence”. The results are summarized in Table 3 and plotted in Figure 9. The obtained curves were adjusted to a monoexponential function to obtain $T_1$. Relaxation values were measured three times, and the average was calculated.

<table><caption>**Table 3.** Measured $1/T_1$ on different concentrations of ligand 2/Gd(III) complex.</caption><thead><tr><td>Concentration (mmol)</td><td>T<sub>1</sub> (s)</td><td>1/T<sub>1</sub> (s<sup>-1</sup>)</td></tr></thead><tbody><tr><td>1.9</td><td>0.068</td><td>14.70588235</td></tr><tr><td>0.95</td><td>0.135</td><td>7.407407407</td></tr><tr><td>0.475</td><td>0.284</td><td>3.521126761</td></tr><tr><td>0.2375</td><td>0.49</td><td>2.040816327</td></tr><tr><td>0.11875</td><td>1.01</td><td>0.99009901</td></tr></tbody></table>

<figure><img src="image_16.png" /><figcaption>**Figure 9.** The plot of $1/T_1$ versus the concentration of ligand 2/Gd(III) complex gives a linear line with a slope of 7.6958 mM$^{-1}$s$^{-1}$.</figcaption></figure>
The slope of the fitted line of 1/T₁ versus the concentration of the complex leads to the relaxivity value (r₁), which has a unit of mM⁻¹s⁻¹. Based on the results, the calculated relaxivity of ligand 2/Gd(III) is 7.6958 mM⁻¹s⁻¹ (R² = 0.9995), which is actually much better than the reported relaxivity of the DOTA/Gd(III) complex (r₁ = 3.2 mM⁻¹s⁻¹) [28,29].

The size and molecular weight of the paramagnetic complex can affect the rotational correlation time (τr) and the residence time of water molecules (τm) in the sphere of coordination of gadolinium(III) [17]. Larger molecules have a slower rotation, thus increased τr and faster exchange rate kex decreases of τm, thus improving the relaxivity. The difference in relaxivity of ligand 2/Gd(III) compared to the DOTA/Gd(III) complex can be explained by their large differences in molecular weights (m/z: 888.13 for ligand 2/Gd(III) versus m/z: 558.65 for DOTA-Gd(III)) as well as the presence of several hydroxyl groups in ligand 2, which can potentially interact with water molecules via hydrogen bonding, forming a second coordination sphere. In the DOTA/Gd(III) complex, there is a lack of hydroxyl groups; thus, similar hydrogen bonding with water molecules is absent. In a similar way, higher relaxivity has been observed with the native β-cyclodextrin/Gd(III) complex in comparison with the permethylated β-cyclodextrin/Gd(III) complex, confirming the importance of hydrogen bonding interaction in T₁ measurement [17].

**3. Conclusions**

Sucrose is a highly abundant, low-cost, non-toxic, eco-friendly natural product. We reported a potential application by converting sucrose to useful metal-chelating ligands. The chemistries reported in this work are highly regioselective for both C-6 and C-6' positions, and we demonstrate that two iminoacetate residues can be easily installed on those two positions by taking advantage of the efficient "click" reaction. We further demonstrate that the introduced functionalities can effectively collaborate to form a multidentate first-coordination sphere for lanthanide metal ions. Using gadolinium(III) as a model, we provide evidence that the formed complexes (such as ligand 2) can achieve respectable binding affinity and higher relaxivity. However, because of its lower pGd compared to the Gd-DOTA complex currently used in clinics, it is unlikely for ligand 2 to find clinical applications as a contrast agent in MRI. However, its ability to sequester metal ions can be extended to many other metals, and we, thus, expect ligands based on sucrose scaffolds, such as compound 2, to find utility in many other applications.

**4. Materials and Methods**

**4.1. Chemical Synthesis**

All commercial reagents were used as supplied unless otherwise stated. Analytical thin layer chromatography was performed on Silica Gel 60-F254 TLC Plates (Sigma-Aldrich®, Oakville, ON, Canada) with detection by charring with 5% sulfuric acid in water or a ceric ammonium molybdate dip. Column chromatography was performed on Silica Gel 60 (Silicycle, Ontario, Canada). Organic solutions from extractions were concentrated under vacuum with the assistance of a heat bath. Fourier Transform-InfraRed Spectroscopy was obtained on a Bruker Alpha routine FT-IR spectrometer with ALPHA's Platinum ATR single reflection diamond module in the analysis range and wavenumber from 387 up to 4000 cm⁻¹ in the transmittance mode with 1 s per scan and data collection of 24 scans per analysis. ¹H NMR spectra were recorded at 400 MHz, and ¹³C NMR spectra were recorded at 101 MHz on a Bruker spectrometer. Chemical shifts δH and δC were reported in δ (ppm) and referenced to the residual CHCl₃ (δH 7.24, δC 77.0, CDCl₃) and residual HDO (δH 4.79) of the D₂O solvent and external acetone (δC 29.9). First-order coupling constants were reported in Hz for proton nuclei. ¹H and ¹³C NMR spectra were assigned with the assistance of DEPTQ, GCOSY and GHSQC spectra. High-resolution ESI-QTOF mass spectra were recorded on an Agilent 6520 Accurate Mass Quadrupole Time-of-Flight LC/MS spectrometer.

**2,3,4,1',2',3'-Hexa-O-acetyl-6,6'-diazido-6,6'-dideoxysucrose (5).** Sucrose (1, 2.02 g, 5.90 mmol) was added to anhydrous pyridine (30.0 mL), and the mixture was heated to
110 °C to allow all solids to dissolve. The solution was cooled to an ambient temperature, and Ph₃P (4.61 g, 17.5 mmol) was added. This was followed by the dropwise addition of a solution of CBr₄ (5.82 g, 17.5 mmol) in anhydrous pyridine (10.0 mL). The mixture was then heated to 70 °C for 2 h to form the intermediate 6,6'-dibromide (3) as the major product (based on TLC, CH₂Cl₂:MeOH:H₂O = 7:3:0.1). The solution was cooled down to an ambient temperature, and acetic anhydride (20.0 mL) was added. The mixture was heated to 55 °C for 2 h. The solution was cooled down to an ambient temperature and concentrated under reduced pressure. The residue was dissolved in EtOAc (150 mL), and the organic solution was successively washed with an aqueous solution of HCl (2M, 50 mL), 10% NaHCO₃ (50 mL) and 10% brine (50 mL), dried over anhydrous Na₂SO₄ and evaporated to afford crude per-O-acetylated dibromide (4). The residue was dissolved in anhydrous DMF (20.0 mL), and NaN₃ (2.0 g, 30.8 mmol) was added, and the mixture was heated to 70 °C overnight. The mixture was cooled down to room temperature and diluted with EtOAc (150 mL). The organic solution was extracted with 10% brine (2 × 100 mL), dried over anhydrous Na₂SO₄ and evaporated. The crude material was purified by column chromatography on silica gel using 1% acetone in dichloromethane as the eluent to afford compound 5 in its pure form and as a white foam (2.55 g, 67%). ¹H NMR (400 MHz, CDCl₃) δ 5.60 (d, *J* = 3.7 Hz, 1H, H-1), 5.44–5.33 (m, 2H, H-3 + H-3'), 5.28–5.21 (dd, *J* = 5.9, 5.9 Hz, 1H, H-4'), 4.96 (dd, *J* = 10.2, 9.4 Hz, 1H, H-4), 4.79 (dd, *J* = 10.4, 3.6 Hz, 1H, H-2), 4.21–4.15 (m, 2H, H-1a' + H-5), 4.13 (d, *J* = 12.3 Hz, 1H, H-1b'), 4.08 (ddd, *J* = 7.6, 5.8, 4.2 Hz, 1H, H-5'), 3.62 (dd, *J* = 13.1, 7.5 Hz, 1H, H-6a'), 3.48 (dd, *J* = 13.1, 4.2 Hz, 1H, H-6b'), 3.36 (dd, *J* = 13.4, 2.8 Hz, 1H, H-6a), 3.27 (dd, *J* = 13.4, 5.9 Hz, 1H, H-6b'), 2.10 (s, 3H, OAc), 2.03 (s, 3H, OAc), 2.025 (s, 3H, OAc), 2.02 (s, 3H, OAc), 1.97 (s, 3H, OAc) and 1.94 (s, 3H, OAc). ¹³C NMR (101 MHz, CDCl₃) δ 169.94 (×2, C=O), 169.88 (C=O), 169.87 (C=O), 169.50 (C=O), 169.43 (C=O), 103.95 (C-2), 90.22 (C-1), 80.09 (C-5), 75.89 (C-3'), 75.66 (C-4'), 70.18 (C-2), 69.56 (C-5), 69.21, 69.18 (C-3, C-4), 62.51 (C-1'), 52.72 (C-6'), 50.99 (C-6), 20.56 (Ac), 20.48 (Ac), 20.47 (Ac), 20.44 (Ac), 20.41 (Ac) and 20.33 (Ac). HRMS (ESI-QTOF, positive) *m/z* calculated for C₂₄H₃₂N₆O₁₅Na (M + Na⁺): 667.1818; found 667.1829.

2,3,4,1',2',3'-Hexa-O-acetyl-6,6'-dideoxy-6,6'-(4-((bis(2-methoxycarbonylethyl)amino) methyl)-1H-1,2,3-triazol-1-yl)sucrose (7). Compound 5 (1.0 g, 1.55 mmol) and N,N-bis(methoxycarbonylmethyl)propargylamine (6) (1.18 g, 5.92 mmol, 1.91 equivalents per N₃) were dissolved in acetone (25.0 mL) under an argon atmosphere. N,N-diisopropylethylamine (90 µL, 0.51 mmol) and a catalytic amount of CuI (~60 mg, 0.31 mmol) were added. After stirring the solution at an ambient temperature for 2 days, the mixture was concentrated under reduced pressure. The crude mixture was then dissolved in EtOAc (100 mL) and washed with a saturated solution of EDTA (2 × 30 mL). The organic solution was dried over anhydrous Na₂SO₄ and concentrated under reduced pressure. The crude residue was then purified by column chromatography on silica gel using a gradient of 1→2% MeOH-CH₂Cl₂ as the eluent to afford the desired conjugate 7 (1.34 g, 1.28 mmol, 83% yield). ¹H NMR (400 MHz, CDCl₃) δ 7.67 (s, 1H, H-4_1,2,3-triazole), 7.57 (s, 1H, H-4_1,2,3-triazole), 5.53 (d, *J* = 3.6 Hz, 1H, H-1), 5.38 (dd, *J* = 10.4, 9.4 Hz, 1H, H-3), 5.26 (d, *J* = 4.7 Hz, 1H, H-3'), 5.16 (dd, *J* = 4.6, 4.6 Hz, 1H, H-4'), 4.76 (dd, *J* = 9.7, 9.7 Hz, 1H, H-4), 4.70 (dd, *J* = 10.4, 3.6 Hz, 1H, H-2), 4.53 (dd, *J* = 14.1, 5.6 Hz, 1H, H-6a'), 4.49–4.34 (m, 3H, H-5 + H-6a + H-6b), 4.30 (dd, *J* = 14.1, 7.3 Hz, 1H, H-6b'), 4.19 (ddd, *J* = 7.4, 5.6, 4.5 Hz, 1H, H-5'), 4.00–3.84 (m, 6H, 2 × 1,2,3-triazol-CHaHbN + 2 × 1,2,3-triazol-CHaHbN + H-1a' + H-1b'), 3.58 (s, 6H, 2 × CO₂Me), 3.578 (s, 6H, 2 × CO₂Me), 3.48 (s, 4H, 2 × NCH₂CO₂Me), 3.44 (s, 4H, 2 × NCH₂CO₂Me), 2.07 (s, 3H, Ac), 2.03 (s, 3H, Ac), 1.98 (s, 3H, Ac), 1.95 (s, 3H, Ac), 1.94 (s, 3H, Ac) and 1.92 (s, 3H, Ac). ¹³C NMR (101 MHz, CDCl₃) δ 171.25 (×2, C=O), 171.21 (×2, C=O), 169.97 (C=O), 169.79 (C=O), 169.76 (C=O), 169.63 (C=O), 169.59 (C=O), 169.19 (C=O), 145.03 (C-3_1,2,3-triazole), 144.81 (C-3_1,2,3-triazole), 124.77 (C-4_1,2,3-triazole), 124.23 (C-4_1,2,3-triazole), 104.81 (C-2'), 90.25 (C-1), 80.23 (C-5'), 75.95 (C-4'), 75.33 (C-3'), 70.11 (C-2), 69.41 (C-4), 69.06 (C-5), 68.85 (C-3), 61.23 (C-1'), 54.12 (×2, 2 × NCH₂CO₂Me), 54.09 (×2, 2 × NCH₂CO₂Me), 51.69 (C-6'), 51.46 (CO₂Me), 51.44 (CO₂Me), 50.35 (C-6), 48.85 (1,2,3-triazole-CHaHbN), 48.80 (1,2,3-triazole-CHaHbN), 20.58 (Ac), 20.46 (Ac), 20.43
(Ac), 20.33 (×2, 2 × Ac) and 20.28 (Ac). HRMS (ESI-QTOF, positive) *m/z* calculated for C₄₂H₅₈N₈O₂₃Na (M + Na⁺): 1065.3512; found 1065.3502.

**6,6'-Dideoxy-6,6'-(4-((bis(2-carboxyethyl)amino)methyl)-1H-1,2,3-triazol-1-yl)sucrose, disodium salt (2).** Compound 7 (480 mg, 0.460 mmol) was dissolved in anhydrous MeOH (10.0 mL), and a solution of NaOMe in MeOH (1.0 M, 0.10 mL) was added. The reaction was then stirred under argon overnight and concentrated under reduced pressure. The obtained residue was dissolved in H₂O (5.0 mL). NaOH (110 mg, 2.75 mmol, 1.5 equivalents per carboxylic ester) was then added to the solution, and the mixture was heated at 80 °C under argon overnight. The mixture was then neutralized with dry ice and concentrated under reduced pressure, and the residue was purified by gel filtration chromatography on Sephadex LH-20 using Millipore H₂O as the eluent to afford the desired compound (2), which was subsequently freeze-dried as a white solid (310 mg, 0.398 mmol, 86% yield). ¹H NMR (400 MHz, D₂O) δ 8.37 (s, 1H, H-4_1,2,3-triazole), 8.32 (s, 1H, H-4_1,2,3-triazole), 5.44 (d, *J* = 3.7 Hz, 1H, H-1), 4.93 (dd, *J* = 15.0, 2.7 Hz, 1H, H-6a), 4.85 (overlapped with HDO, 1H, H-6b), 4.73 (s, 2H, 1,2,3-triazole-CHaHbN), 4.71–4.55 (m, 3H, 1,2,3-triazole-CHaHbN + H-6a'), 4.36 (ddd, *J* = 9.6, 6.7, 2.6 Hz, 1H, H-5), 4.30–4.10 (m, 3H, H-3' + H-6b' + H-5'), 4.00–3.85 (m, 9H, H-4' + 4 × NCH₂CO₂), 3.82 (dd, *J* = 9.5, 9.5 Hz, 1H, H-3), 3.69–3.52 (m, 3H, H-1a' + H-2 + H-1b') and 3.26 (dd, *J* = 9.6, 9.6 Hz, 1H, H-4). ¹³C NMR (101 MHz, D₂O) δ 170.13 (×2, C=O), 136.77 (C-3_1,2,3-triazole), 136.70 (C-3_1,2,3-triazole), 129.03 (C-4_1,2,3-triazole), 128.19 (C-4_1,2,3-triazole), 104.18 (C-2'), 92.30 (C-1), 78.65 (C-5'), 75.95 (C-3'), 75.36 (C-4'), 72.06 (C-3), 70.98 (C-5), 70.76 (C-4), 70.64 (C-2), 61.10 (C-1'), 56.31 (×2, 2 × NCH₂CO₂), 56.29 (×2, 2 × NCH₂CO₂), 52.85 (C-6'), 51.47 (C-6), 48.95 (1,2,3-triazole-CH₂N) and 48.81 (1,2,3-triazole-CH₂N). HRMS (ESI-QTOF, negative) *m/z* calculated for C₂₆H₃₅N₈O₁₇ (M-H)⁻: 733.2282; found 733.2289; *m/z* calculated for C₂₆H₃₅N₈O₁₇ (M-2H)²⁻: 366.1105; found 366.1114.

## 4.2. *Preparation of Ligand 2/Gd(III) Complex*

Ligand 2 (14.3 mg, 19 µmol) was dissolved in Milli-Q water (1 mL) to obtain a solution (19 mM concentration). The pH was adjusted between 6 and 7 with a 0.01 M NH₄OH solution. A volume (1 µL) of the GdCl₃ solution (21 mM, 1.1 equivalent) was added to the solution of ligand 2. The pH was adjusted several times to be maintained between 6 and 7 during the reaction. The reaction mixture was stirred for 24 h. Thereafter, the solution was dialyzed for 24 h in a spectrum Por (MWCO: 0.5 kDa) dialysis tube closed at both ends by Mohr clamps and suspended in a crystallizer filled with Milli-Q water (changed regularly every 2 h). The solution was then lyophilized to afford a white solid (17.1 mg), which is hygroscopic.

## 4.3. *Ligand 2 Protonation Studies*

All solutions were prepared with Milli-Q water and degassed by argon saturation in order to remove dissolved CO₂. A total of 0.01 M HCl was prepared from standard Titrisol (Merck, Rahway, NJ, USA) and adjusted to I = 0.1 M with NMe₄Cl. This solution was used to calibrate the Metrohm combined glass microelectrode. Carbonate-free NMe₄OH solution (ca. 0.05 M) was standardized against potassium hydrogen phthalate (RPE, Carlo Erba) by potentiometry, recording e.m.f. (mV) after each base addition.

Alkali metal ions have strong tendencies to form partially dissociated complexes in solutions with carboxylate ions. The affinity of this association tends to increase with the number of carboxylic acid groups of the acid anion. Therefore, potentiometric studies were performed using tetramethylammonium chloride (NMe₄Cl) as a background electrolyte.

The ionic product of water was determined by titrating an acetic solution in 0.1 M NMe₄Cl at different concentrations. Under these conditions, pKw = 13.78. This value was used in the calculations.

Automatic titrations were carried out with a 905 Metrohm Titrando apparatus equipped with an 800 Dosino 2 mL burette connected to a computer. The delivery of the titrant, data acquisition and monitoring for e.m.f. stability were controlled by Tiamo 2.2 software. The burette is capable of delivering titrant solution at an increment of 0.2 µL volumes. Sample
solutions were titrated in a double-walled, glass-reaction vessel fitted with a sealed lid containing ports for the glass combination electrode (Metrohm #6.0234.100), Teflon anti-diffusion burette tip and Teflon gas line. All titrations were performed at 25 ± 0.2 °C in the thermostatic cell using a thermocirculator bath (Julabo HE cryostat) under an argon stream to avoid the dissolution of carbon dioxide. The electrode slope was checked by titration with an HCl solution. Linear behavior was observed in the range of pH 2 to 12.

All equilibrium measurements were carried out in 4.0 mL sample volumes under magnetic stirring. The ionic strength was adjusted to 0.1 N with NMe₄Cl. The ligand stock solution was prepared by dissolution of a weighted amount of ligand in an appropriate amount of 0.1 M NMe₄Cl solution. In our experiments, the ligand **2** concentration of the stock solution was equal to 10⁻³ M. Titrations with NMe₄OH were carried out in the presence of extra HCl to ensure the initial protonation of carboxylate groups. The initial volume of the measured solution was 4.0 mL, and the ligand concentration varied from 1.25 × 10⁻⁴ to 1.0 × 10⁻³ M. Before the first point acquisition, the reaction cell was sealed, and the solution was stirred and sparged with argon for 10 min. Finally, the sample solution was titrated to ca. pH 12 with standardized NMe₄OH in a monotonic mode. Increments of the base added were fixed at 4 µL. The electrode was monitored for up to 6 min or until its drift was less than 0.4 mV/min before recording an mV reading. The protonation constants of ligand **2** were determined from ten titrations.

The concentration of the ligand was calculated from potentiometric data (e.m.f.) during the determination of the protonation constants processed with the general computation program HYPERQUAD [30]. In HYPERQUAD, the stability constant, β (not log β), is the parameter that is refined, and by default, a standard deviation was labeled as excessive if it was more than 33% of the parameter value. Although this value is user-definable, the default value of 33% was used for this work.

### 4.4. *Stability Constant Measurement*

Stock solutions of metal chloride were prepared from commercially (gadolinium (III) chloride hydrate, Strem Chemicals) available reagents of purity higher than 99.9% in distilled water and diluted to the required concentrations. Their ionic strength was adjusted to 0.1 M with NMe₄Cl. The exact concentration of metal chloride stock solution was determined by complexometric titrations with ethylenediaminetetraacetic acid disodium salt dihydrate (Titriplex® III, Merck) in acetate buffer (50 mM, pH 5.8) using an xylenol orange indicator (Merck, ACS reagent) [31].

Stability constants of gadolinium–ligand **2** were determined from seventeen titrations using solutions containing 0 to over 1 equivalent of metal, with an initial ligand and HCl concentration equal, respectively, to 5 × 10⁻⁴ M and 3.45 × 10⁻³ M.

The same method was used for the metal–ligand stability constant determination.

The computer program HYSS was used to obtain the speciation distribution curves [30,32].

### 4.5. *Relaxivity Measurements*

Relaxivity measurements were performed on a Brucker mq20 Minispec at 37 °C and 0.47 T (20 MHz). The relaxation time T₁ of each concentration was determined using the “Inversion Recovery Pulse Sequence”. The resulting curves were adjusted to a monoexponential function to obtain T₁. Relaxation values were measured three times, and the average was calculated. The concentration of gadolinium was verified by ICP-OES (iCAP Series 6000, Thermo Scientific, Waltham, MA, USA) at 336.2 nm. Calibration was performed in 2% HNO₃ solutions with Gd concentrations ranging from 0.1 to 2.0 mg/L. The Gd complex was diluted in 2% HNO₃ before analysis by ICP-OES.

**Supplementary Materials:** The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29194688/s1. Figure S1: ¹H NMR spectrum of compound **5** in CDCl₃, 400 MHz, 298 K; Figure S2: ¹³C NMR spectrum of compound **5** in CDCl₃, 100 MHz, 298 K; Figure S3: ¹H-¹H 2D GCOSY NMR spectrum of compound **5** in CDCl₃, 400 MHz, 298 K; Figure S4: ¹H-¹³C 2D GHSQC NMR spectrum of compound **5** in CDCl₃, 400 MHz, 298 K; Figure S5: ¹H NMR
spectrum of compound 7 in CDCl₃, 400 MHz, 298 K; Figure S6: ¹³C NMR spectrum of compound 7 in CDCl₃, 100 MHz, 298 K; Figure S7: ¹H-¹H 2D GCOSY NMR spectrum of compound 7 in CDCl₃, 400 MHz, 298 K; Figure S8: ¹H-¹³C 2D GHSQC NMR spectrum of compound 7 in CDCl₃, 400 MHz, 298 K; Figure S9: ¹H NMR spectrum of compound 2 in D₂O, 400 MHz, 298 K; Figure S10: ¹³C NMR spectrum of compound 2 in D₂O, 100 MHz, 298 K; Figure S11: ¹H-¹H 2D GCOSY NMR spectrum of compound 2 in D₂O, 400 MHz, 298 K; Figure S12: ¹H-¹³C 2D GHSQC NMR spectrum of compound 2 in D₂O, 400 MHz, 298 K.

**Author Contributions:** Chemical synthesis, P.Z. and C.L.; potentiometry, C.B.; proton relaxivity, R.G.; ATR-FTIR, L.G.; writing—original draft preparation, P.Z., C.B., R.G., G.G. and C.-C.L.; writing—review and editing: P.Z., C.B., R.G., L.G., G.G. and C.-C.L.; project administration and supervision: C.-C.L. and G.G.; fund acquisition: C.-C.L. and G.G.; conceptualization: C.-C.L. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), grant number RGPIN/04320-2018. This research was funded by Normandy Region and FEDER in RIN Tremplin Neuroncochimie Program.

**Data Availability Statement:** The data are contained within the article.

**Acknowledgments:** This work has also been partially supported by the University of Rouen Normandy, Centre National de la Recherche Scientifique (CNRS), INSA Rouen Normandy, European Regional Development Fund (ERDF), Labex SynOrg (ANR-11-LABX-0029), Carnot Institute I2C and the graduate school for research XL-Chem (ANR-18-EURE-0020XL CHEM).

**Conflicts of Interest:** The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

## References

1. Queneau, Y.; Jarosz, S.; Lewandowski, B.; Fitremann, J. Sucrose Chemistry and Applications of Sucrochemicals. *Adv. Carbohydr. Chem. Biochem.* **2007**, *61*, 217–292. [CrossRef] [PubMed]

2. Lichtenthaler, F.W.; Peters, S. Carbohydrates as Green Raw Materials for the Chemical Industry. *C. R. Chim.* **2004**, *7*, 65–90. [CrossRef]

3. Jarosz, S.; Sokołowska, P.; Szyszka, Ł. Synthesis of Fine Chemicals with High Added Value from Sucrose: Towards Sucrose-Based Macrocycles. *Tetrahedron Lett.* **2020**, *61*, 151888–151902. [CrossRef]

4. Petrova, K.T.; Correia-da-Silva, P.; Crucho, C.I.C.; Barros, M.T. Chemoselective Synthesis of Sucrose Building Blocks and Their Polymerization. *Curr. Org. Chem.* **2014**, *18*, 1788–1802. [CrossRef]

5. Kordován, M.Á.; Hegedűs, C.; Czifrák, K.; Lakatos, C.; Kálmán-Szabó, I.; Daróczi, L.; Zsuga, M.; Kéki, S. Novel Polyurethane Scaffolds Containing Sucrose Crosslinker for Dental Application. *Int. J. Mol. Sci.* **2022**, *23*, 7904. [CrossRef] [PubMed]

6. Nagtode, V.S.; Cardoza, C.; Yasin, H.K.A.; Mali, S.N.; Tambe, S.M.; Roy, P.; Singh, K.; Goel, A.; Amin, P.D.; Thorat, B.R.; et al. Green Surfactants (Biosurfactants): A Petroleum-Free Substitute for Sustainability—Comparison, Applications, Market, and Future Prospects. *ACS Omega* **2023**, *8*, 11674–11699. [CrossRef] [PubMed]

7. Allen, D.K.; Tao, B.Y. Carbohydrate-Alkyl Ester Derivatives as Biosurfactants. *J. Surfactants Deterg.* **1999**, *2*, 383–390. [CrossRef]

8. Plat, T.; Linhardt, R.J. Syntheses and Applications of Sucrose-Based Esters. *J. Surfactants Deterg.* **2001**, *4*, 415–421. [CrossRef]

9. Bimal, C.; Guonong, Z. Olestra: A Solution to Food Fat? *Food Rev. Int.* **2006**, *22*, 245–258. [CrossRef]

10. Shankar, P.; Ahuja, S.; Sriram, K. Non-Nutritive Sweeteners: Review and Update. *Nutrition* **2013**, *29*, 1293–1299. [CrossRef]

11. Schiffman, S.S.; Rother, K.I. Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. *J. Toxicol. Environ. Health Part B* **2013**, *16*, 399–451. [CrossRef] [PubMed]

12. Kang, A.; Lee, T.S. Converting Sugars to Biofuels: Ethanol and Beyond. *Bioengineering* **2015**, *2*, 184–203. [CrossRef] [PubMed]

13. Galkin, K.I.; Ananikov, V.P. When Will 5-Hydroxymethylfurfural, the "Sleeping Giant" of Sustainable Chemistry, Awaken? *ChemSusChem* **2019**, *12*, 2976–2982. [CrossRef] [PubMed]

14. Lattuada, L.; Barge, A.; Cravotto, G.; Giovenzana, G.B.; Tei, L. The Synthesis and Application of Polyamino Polycarboxylic Bifunctional Chelating Agents. *Chem. Soc. Rev.* **2011**, *40*, 3019–3049. [CrossRef] [PubMed]

15. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. *Angew. Chem. Int. Ed.* **2001**, *40*, 2004–2021. [CrossRef]

16. Thirumurugan, P.; Matosiuk, D.; Jozwiak, K. Click Chemistry for Drug Development and Diverse Chemical-Biology Applications. *Chem. Rev.* **2013**, *113*, 4905–4979. [CrossRef]

17. Sembo-Backonly, B.S.; Estour, F.; Gouhier, G. Cyclodextrins: Promising Scaffolds for MRI Contrast Agents. *RSC Adv.* **2021**, *11*, 29762–29785. [CrossRef]
18. Champagne, P.-L.; Barbot, C.; Zhang, P.; Han, X.; Gaamoussi, I.; Hubert-Roux, M.; Bertolesi, G.E.; Gouhier, G.; Ling, C.-C. Synthesis and Unprecedented Complexation Properties of β-Cyclodextrin-Based Ligand for Lanthanide Ions. *Inorg. Chem.* **2018**, *57*, 8964–8977. [CrossRef]

19. Abboud, J.-L.M.; Foces-Foces, C.; Notario, R.; Trifonov, R.E.; Volovodenko, A.P.; Ostrovskii, V.A.; Alkorta, I.; Elguero, J. Basicity of N-H- and N-Methyl-1,2,3-Triazoles in the Gas Phase, in Solution, and in the Solid State – An Experimental and Theoretical Study. *Eur. J. Org. Chem.* **2001**, *2001*, 3013–3024. [CrossRef]

20. Arzik, S.; Ayan, E.M.; Celebi, A.S. Potentiometric Determination of the Stability Constants of Lanthanide Complexes with Iminodiacetic Acid in Water and Dioxane-Water Mixtures. *Turk. J. Chem.* **2008**, *32*, 721–729.

21. Nakamoto, K. *Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications in Coordination, Organometallic, and Bioinorganic Chemistry*, 6th ed.; Wiley-Interscience: Hoboken, NJ, USA, 2009; ISBN 978-0-471-74493-1.

22. Deacon, G.B.; Phillips, R.J. Relationships between the Carbon-Oxygen Stretching Frequencies of Carboxylato Complexes and the Type of Carboxylate Coordination. *Coord. Chem. Rev.* **1980**, *33*, 227–250. [CrossRef]

23. Kumar, K.; Chang, C.A.; Francesconi, L.C.; Dischino, D.D.; Malley, M.F.; Gougoutas, J.Z.; Tweedle, M.F. Synthesis, Stability, and Structure of Gadolinium(III) and Yttrium(III) Macrocyclic Poly(Amino Carboxylates). *Inorg. Chem.* **1994**, *33*, 3567–3575. [CrossRef]

24. Davies, J.; Siebenhandl-Wolff, P.; Tranquart, F.; Jones, P.; Evans, P. Gadolinium: Pharmacokinetics and Toxicity in Humans and Laboratory Animals Following Contrast Agent Administration. *Arch. Toxicol.* **2022**, *96*, 403–429. [CrossRef] [PubMed]

25. Fatin-Rouge, N.; Bünzli, J.-C.G. Thermodynamic and Structural Study of Inclusion Complexes between Trivalent Lanthanide Ions and Native Cyclodextrins. *Inorganica Chim. Acta* **1999**, *293*, 53–60. [CrossRef]

26. Gamov, G.A.; Zavalishin, M.N.; Pimenov, O.A.; Klochkov, V.V.; Khodov, I.A. La(III), Ce(III), Gd(III), and Eu(III) Complexation with Tris(Hydroxymethyl)Aminomethane in Aqueous Solution. *Inorg. Chem.* **2020**, *59*, 17783–17793. [CrossRef]

27. Nonat, A.; Giraud, M.; Gateau, C.; Fries, P.H.; Helm, L.; Mazzanti, M. Gadolinium(III) Complexes of 1,4,7-Triazacyclononane Based Picolinate Ligands: Simultaneous Optimization of Water Exchange Kinetics and Electronic Relaxation. *Dalton Trans.* **2009**, *38*, 8033–8046. [CrossRef]

28. Caravan, P.; Ellison, J.J.; McMurry, T.J.; Lauffer, R.B. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. *Chem. Rev.* **1999**, *99*, 2293–2352. [CrossRef]

29. Dai, L.; Jones, C.M.; Chan, W.T.K.; Pham, T.A.; Ling, X.; Gale, E.M.; Rotile, N.J.; Tai, W.C.-S.; Anderson, C.J.; Caravan, P.; et al. Chiral DOTA Chelators as an Improved Platform for Biomedical Imaging and Therapy Applications. *Nat. Commun.* **2018**, *9*, 857. [CrossRef]

30. Gans, P.; Sabatini, A.; Vacca, A. Investigation of Equilibria in Solution. Determination of Equilibrium Constants with the HYPERQUAD Suite of Programs. *Talanta* **1996**, *43*, 1739–1753. [CrossRef]

31. Barge, A.; Cravotto, G.; Gianolio, E.; Fedeli, F. How to Determine Free Gd and Free Ligand in Solution of Gd Chelates. A Technical Note. *Contrast Media Mol. Imaging* **2006**, *1*, 184–188. [CrossRef]

32. Alderighi, L.; Gans, P.; Ienco, A.; Peters, D.; Sabatini, A.; Vacca, A. Hyperquad Simulation and Speciation (HySS): A Utility Program for the Investigation of Equilibria Involving Soluble and Partially Soluble Species. *Coord. Chem. Rev.* **1999**, *184*, 311–318. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.